The mRNA-based supplier of vaccines profited from Covid-19 vaccine sales. As the years passed, Covid evolved. The weaker ...

We recently compiled a list of the 10 High-Flying Stocks to Buy Now. In this article, we are going to take a look at where ...

We recently compiled a list of the 7 Best Under The Radar Stocks to Buy According to Analysts. In this article, we are going ...

Novavax's protein-based shot is an option for COVID vaccination this season, joining refreshed formulas from Moderna and ...

Shares of Novavax Inc. NVAX shed 5.62% to $13.61 Friday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP rising 1.22% to ...

On Thursday, Novavax Inc (NVAX) stock saw a decline, ending the day at $14.42 which represents a decrease of $-0.26 or -1.77% from the prior close of $14.68. The stock opened at $14.07 and touched a ...

The federal government's decision to not provide Novavax's COVID-19 vaccine this respiratory virus season raises health equity concerns, experts and advocates say.

Novavax (NVAX) stock fell after a clarification on an analyst report led to a sharp rally in the company stock in the ...

With cold and flu season ramping up some Canadians have been travelling south of the border and paying hundreds of dollars to ...